These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2152631)

  • 21. The use of saliva as a biological fluid in relative bioavailability studies: comparison and correlation with plasma results.
    Ruiz ME; Conforti P; Fagiolino P; Volonté MG
    Biopharm Drug Dispos; 2010 Nov; 31(8-9):476-85. PubMed ID: 20878879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioavailability of ergoloid mesylates liquid capsule.
    Schran HF
    Clin Ther; 1985; 8(1):71-5. PubMed ID: 3833371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
    Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M
    Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative bioavailability study of clonazepam after oral administration of two tablet formulations.
    Chauhan BL; Sane SP; Revankar SN; Rammamurthy L; Doshi B; Bhatt AD; Bhate VR; Kulkarni RD
    J Assoc Physicians India; 2000 Oct; 48(10):985-7. PubMed ID: 11200924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative bioavailability study of a conventional and two controlled release oral formulations of Tegretol (carbamazepine)--200 mg.
    Revankar SN; Bhatt AD; Desai ND; Bolar HV; Sane SP; Tipnis HP
    J Assoc Physicians India; 1999 Sep; 47(9):886-9. PubMed ID: 10778658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
    Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A multiple-dose safety and bioequivalence study of a narrow therapeutic index drug: a case for carbamazepine.
    Yacobi A; Zlotnick S; Colaizzi JL; Moros D; Masson E; Abolfathi Z; LeBel M; Mehta R; Golander Y; Levitt B
    Clin Pharmacol Ther; 1999 Apr; 65(4):389-94. PubMed ID: 10223775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single-dose kinetics of an enteric-coated formulation of carbamazepine-10,11-epoxide, an active metabolite of carbamazepine.
    Spina E; Tomson T; Svensson JO; Faigle JW; Bertilsson L
    Ther Drug Monit; 1988; 10(4):382-5. PubMed ID: 3201523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bioavailability and pharmacokinetics of furosemide marketed in Thailand.
    Kaojarern S; Poobrasert O; Utiswannakul A; Kositchaiwat U
    J Med Assoc Thai; 1990 Apr; 73(4):191-7. PubMed ID: 2394955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relative bioavailability of ondansetron 8-mg oral tablets versus two extemporaneous 16-mg suppositories: formulation and gender differences.
    Jann MW; ZumBrunnen TL; Tenjarla SN; Ward ES; Weidler DJ
    Pharmacotherapy; 1998; 18(2):288-94. PubMed ID: 9545148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of two marketed nifedipine modified-release formulations: an exploratory clinical food interaction study.
    Wonnemann M; Schug B; Anschütz M; Brendel E; De Nucci G; Blume H
    Clin Ther; 2008 Jan; 30(1):48-58. PubMed ID: 18343242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Absolute and relative bioavailability of the HMG-CoA reductase inhibitor cerivastatin.
    Mück W; Ritter W; Ochmann K; Unger S; Ahr G; Wingender W; Kuhlmann J
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):255-60. PubMed ID: 9208342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro evaluation of carbamazepine 200 mg tablets.
    Kibwage IO; Nguyo M
    East Afr Med J; 1993 Aug; 70(8):512-4. PubMed ID: 8261973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Population pharmacokinetic model of carbamazepine derived from routine therapeutic drug monitoring data.
    Vucićević K; Miljković B; Velicković R; Pokrajac M; Mrhar A; Grabnar I
    Ther Drug Monit; 2007 Dec; 29(6):781-8. PubMed ID: 18043476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of bio(in)equivalence of deriphyllin-digoxin in human volunteers. II. Evaluation of rabbits as qualitative animal model.
    Bansinath M; Ghosh SS; Shukla VK; Chopra KS; Mathur VS
    Methods Find Exp Clin Pharmacol; 1986 May; 8(5):303-7. PubMed ID: 3724304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Study on the absolute bioavailability of quinine and theophylline from tablets after single dose oral administration as compared to intravenous infusion in healthy male non-smoking volunteers.
    Fuder H; Herzog R; Vaupel W; Wetzelsberger N; Lücker PW
    Methods Find Exp Clin Pharmacol; 1994 Nov; 16(9):651-60. PubMed ID: 7746027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of food on the bioavailability of a carbamazepine slow-release formulation.
    Retzow A; Schürer M; Schulz HU
    Int J Clin Pharmacol Ther; 1997 Dec; 35(12):557-60. PubMed ID: 9455713
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the pharmacokinetics and pharmacodynamics of two commercial products containing glibenclamide.
    el-Sayed YM; Suleiman MS; Hasan MM; Abdel-Hamid ME; Najib NM; Sallam ES; Shubair MS
    Int J Clin Pharmacol Ther Toxicol; 1989 Nov; 27(11):551-7. PubMed ID: 2515159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative bioavailability of two atenolol tablet formulations in healthy male volunteers after a single dose administration.
    Martins ML; Pierossi MA; Moraes LA; Ribeiro W; Abbib Júnior E; Mendes GB; Poli A; De Nucci G; Muscará MN
    Int J Clin Pharmacol Ther; 1997 Aug; 35(8):324-8. PubMed ID: 9266287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative bioavailability of two commercial preparations of carbamazepine tablets.
    Anttila M; Kahela P; Panelius M; Yrjänä T; Tikkanen R; Aaltonen R
    Eur J Clin Pharmacol; 1979 Jul; 15(6):421-5. PubMed ID: 583039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.